Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)

HKG:2315 Statistics

Total Valuation

HKG:2315 has a market cap or net worth of HKD 41.27 billion. The enterprise value is 41.55 billion.

Market Cap	41.27B
Enterprise Value	41.55B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2315 has 436.90 million shares outstanding. The number of shares has increased by 1.20% in one year.

Current Share Class	100.78M
Shares Outstanding	436.90M
Shares Change (YoY)	+1.20%
Shares Change (QoQ)	+3.30%
Owned by Insiders (%)	14.39%
Owned by Institutions (%)	19.03%
Float	146.77M

Valuation Ratios

The trailing PE ratio is 122.15 and the forward PE ratio is 70.66.

PE Ratio	122.15
Forward PE	70.66
PS Ratio	26.89
PB Ratio	37.83
P/TBV Ratio	40.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	215.55
EV / Sales	27.08
EV / EBITDA	125.02
EV / EBIT	197.97
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.61
Debt / EBITDA	2.00
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 19.04% and return on invested capital (ROIC) is 14.16%.

Return on Equity (ROE)	19.04%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	14.16%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.91%
Revenue Per Employee	1.17M
Profits Per Employee	147,579
Employee Count	1,306
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:2315 has paid 16.50 million in taxes.

Income Tax	16.50M
Effective Tax Rate	7.89%

Stock Price Statistics

The stock price has increased by +286.57% in the last 52 weeks. The beta is 0.32, so HKG:2315's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+286.57%
50-Day Moving Average	49.33
200-Day Moving Average	32.12
Relative Strength Index (RSI)	59.63
Average Volume (20 Days)	1,393,242

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2315 had revenue of HKD 1.53 billion and earned 192.74 million in profits. Earnings per share was 0.48.

Revenue	1.53B
Gross Profit	1.53B
Operating Income	209.85M
Pretax Income	209.24M
Net Income	192.74M
EBITDA	332.31M
EBIT	209.85M
Earnings Per Share (EPS)	0.48

Balance Sheet

The company has 391.27 million in cash and 665.81 million in debt, with a net cash position of -274.55 million or -0.63 per share.

Cash & Cash Equivalents	391.27M
Total Debt	665.81M
Net Cash	-274.55M
Net Cash Per Share	-0.63
Equity (Book Value)	1.09B
Book Value Per Share	2.79
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	124.70M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 13.68% and 12.56%.

Gross Margin	100.00%
Operating Margin	13.68%
Pretax Margin	13.64%
Profit Margin	12.56%
EBITDA Margin	21.66%
EBIT Margin	13.68%
FCF Margin	n/a

Dividends & Yields

HKG:2315 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.20%
Shareholder Yield	-1.20%
Earnings Yield	0.47%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2